A global leader in medical technologies, Australia offers investment opportunities ranging from discovery research through to product development partnerships in biotech, pharmaceuticals, medical devices, tropical medicines and digital health areas. Investors can benefit from:

  • research excellence and a collaborative culture
  • accessible world-class research infrastructure
  • a track record of commercial success
  • an ideal market for testing new innovative medical products/technologies
  • Australia’s trade, investment and cultural ties to the fast-growing Asia-Pacific region.

Australia has a strong but flexible regulatory regime including strong intellectual property (IP) protection, fast-tracked clinical trials, tax incentives and a supportive business culture for undertaking research and development (R&D).

Capabilities

Investor Update

14 Apr 2022

Hanwha Defense starts construction on new armoured vehicle centre of excellence in Victoria

Read more

12 Apr 2022

Australian investments put NCS on path to become a regional digital services powerhouse

Read more

11 Apr 2022

Frucor Suntory to build A$400m manufacturing facility in Australia

Read more

17 Mar 2022

Australia and Korea sign MoU on vaccine research

Read more

10 Mar 2022

Brightmark builds Australia’s first advanced recycling facility

Read more

7 Mar 2022

TCS revs up Australian innovation with new Digital Garage

Read more